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Optimum therapeutic approach in vaginal agenesis has always been an area of extensive controversies. Although surgical manage-
ment gained priority due to the evolution of techniques, there is currently no consensusin the literature regarding the best type of
surgical approach. The most commonly preferred surgical procedure among gynecologists is McIndoe operation which involves
thecreation ofa spacebetween bladder andrectum, insertion ofa moldcovered withsplit-thicknessskingraftinto thatneovaginal
space, and use of postoperative vaginal dilation to avoid stenosis. However, many modiﬁcations have been introduced in time in
an attempt to increase the success rates. In this paper, we describe two cases with vaginal agenesis with functioning uterus who
were subjected to surgery by combined abdominal-perineal approach. The surgical technique also included the use of a specially
designed vaginal mold made up of polymethyl methacrylate and use of Hyalobarrier gel which is an adhesion-preventing agent.
1.Introduction
Vaginalagenesisisarareconditionwithanincidenceranging
from1in4,000to1in10,000females[1].Themostcommon
etiology is Rokitansky-K¨ uster-Hauser-Mayer (RKHM) syn-
dromeorMullerian agenesiswhich isdescribedascongenital
absence of uterus and vagina in an individual with normal
female genotype, normal secondary sexual characteristics,
and normal ovaries. Vaginal agenesis may also occur as an
isolated abnormality [2, 3].
Detection of vaginal agenesis is readily achieved through
well-deﬁned diagnostic steps performed for primary amen-
orrhea at puberty [2]. However, the optimum therapeutic
approach has always been an area of extensive controversies.
Although surgical management gained priority due to the
evolution of techniques, there is currently no consensus in
theliteratureregarding thebesttypeofsurgicalapproach[4].
Themostcommonlypreferredsurgicalprocedureamonggy-
necologistsisMcIndoeoperation which involvesthecreation
of a space between bladder and rectum, insertion of a mold
covered with split-thickness skin graft into that neovaginal
space, and use of postoperative vaginal dilation to avoid
stenosis [3, 5, 6]. Many modiﬁcations have been introduced
in course of time regarding the mold features, surgical tech-
nique,and postoperativecaretoobtainincreased therapeutic
success with relatively low morbidity.
The aim of this paper is to report two cases of vaginal
agenesiswithfunctioninguteruswhoweresubjectedtoanew
surgical technique including the use of a specially designed
vaginal mold made up of polymethyl methacrylate and use
of Hyalobarrier gel, an agent originally used to prevent post-
operative adhesions.
2.Case One
A 14-year-old girl who had normal female genotype and
normal secondary sexual characteristics presented with pri-
mary amenorrhea and cyclic pelvic pain. Pelvic examination
revealed vaginal dimple without a normal vaginal oriﬁce,
and an enlarged uterus was palpated on rectoabdominal
examination. On pelvic magnetic resonance imaging (MRI),
the uterus which was enlarged due to hematometra was
deviated to left side, and a left-sided hematosalpinx was
detected.Theovarieslookednormal.Surgicaltreatmentwith
a preoperative diagnosis of vaginal agenesis was scheduled2 Case Reports in Medicine
Figure 1: Neovaginal space created by blunt dissection.
after adetailedcounselingregarding thesurgicalmethod and
its possible complications.
The patient had an overnight fasting before the day of
surgery. A single intravenous dose of 1000mg cefazolin was
given 30 minutes before the operation for antimicrobial
prophylaxis.Undergeneralanesthesia, thepatientwasplaced
in the dorsal lithotomy position. However, in order to
allow the combined perineal-abdominal approach, the lower
extremities placed in stirrups were positioned with the
hips abducted 45 degrees and ﬂexed 45 degrees. After
catheterization of bladder, the abdominal and vulvar areas
were cleaned and draped. The operation began with a
transverse incision at the site of vaginal dimple. A potential
space was created between the bladder and urethra in front
andrectumbehindbybluntdissection.Thesurgeonpalpated
the catheter in bladder and assistant’s ﬁnger in rectum to
avoid vesical or rectal injury during the dissection. The
dissection continued until a neovagina was obtained with a
length of 9-10cm and a diameter of 3-4cm. The walls of the
cavity were carefully checked for hemostasis (Figure 1).
After the creation of neovagina, a second surgeon per-
formed a laparotomy via pfannenstiel incision. On explora-
tion, both ovaries and right Fallopian tube were normal.
A rudimentary uterine horn was detected on the right side
which seemed to be nonfunctioning, and no hematometra
or hematosalpinx was evident (Figure 2). On the left side,
a relatively enlarged uterine horn and hematosalpinx were
seen (Figure 3). Hematoma within the left tube was drained,
and neosalpingostomy was performed which was secured via
eversion provided by 3.0 polyglactin sutures. A hystero-
tomy was performed subsequently on right anterolateral
fundal portion of left uterine horn. The uterine cavity was
identiﬁed, and hematometra was drained. The cavity was
catheterized with a hysterometer which was pushed slowly
downward until neovaginal space was accessed (Figure 4).
The hysterometer used was a straight, graduated,and sound-
ing metal hysterometer with a rounded tip which was
slightly conical with outside diameters ranging from 3 to
5 millimeters. The specially designed vaginal mold was
insert-ed into the neovagina with an 8-french pediatric
Foley catheter placed in its central lumen (Figure 5). The
Figure 2: Right rudimentary uterine horn (black arrow) with
normaltube and ovary.
Figure 3: Enlarged left uterine horn (black arrow) with hematos-
alpinx (red arrow).
tip of the Foley catheter was located in the uterine cavity,
and its balloon was insuﬄated with 3mL saline (Figure 6).
Endometrium and myometrium were closed separately with
2.0 interrupted polyglactin sutures. To maintain the mold in
position, sutures were put in between labia majora and the
small holes located at the distal end of the mold with 1.0
polyglactin sutures (Figure 7). Hyalobarrier gel was applied
between neovaginal walls and the mold.
The bladder catheter and the mold were maintained for
10 days postoperatively. Because mobilization was restricted,
low-molecular-weight heparin was administered twice a day,
andthepatientwasgivenlow-residuedietduringthisperiod.
After removing the mold, the patient was advised to use the
mold almost constantly for 3 months postoperatively and
at nights for the subsequent 3 months to prevent stricture
of the neovagina. The mold had to be cleaned on a daily
basis, and the patient was explained the method of cleaning
and inserting the mold on her own. 10% iodine and 3%
hydrogen peroxide solutions were used, respectively, for
cleaning the mold. Then, for lubrication and to support an
enhanced epithelization, the mold was covered with 0.1%
estriol cream just before the insertion. Gauze bandages tied
around the waist and upper calves were used to maintainCase Reports in Medicine 3
Figure 4: Uterine cavity catheterized with a hysterometer which is
pushed downward until neovaginal space was accessed.
Figure 5: The specially designed vaginal mold with an 8-french
pediatric Foley catheter placed in its central lumen.
the mold in the neovagina after removing the sutures put
in between labia majora and the mold. The patient was
discharged from hospital on 14th postoperative day with an
uneventfulpostoperativecourse.Herlastvisitwas1yearafter
the operation, and she experienced regular menses without
pain. Her neovagina was patent on examination with normal
cervix and uterus.
3.CaseTwo
A 16-year-old girl having normal female genotype and nor-
mal secondary sexual characteristics presented with primary
amenorrhea and cyclic pelvic pain. On pelvic examination,
she did not have vaginal oriﬁce, and her uterus was enlarged
on rectal examination. Pelvic MRI could not detect a normal
vagina, but uterus was ﬁlled with blood and proximal vagina
was dilated due to proximal hematocolpos. The ovaries were
normal. After counseling the patient and her family, surgery
was planned with a preoperative diagnosis of distal vaginal
agenesis.
After similar preoperative preparation and anesthesia
induction, bladder was catheterized, and abdominal and
vulvar areas were cleaned and draped. A transverse incision
was done on vaginal dimple. A space with a length of 4-5cm
and a diameter of 2-3cm was created by blunt dissection
until proximal vagina was reached and hematometra and
proximal hematocolpos drained. Hemostasis was achieved.
Second surgeon started laparotomy via pfannenstiel
incision. On exploration, ovaries, tubes, and uterus were
normal. Hysterotomy was performed on uterine fundus
to identify endometrial cavity. The cavity was catheterized
with a hysterometer which extended into neovaginal space.
Vaginal mold was inserted into the neovagina with Foley
catheter placed in its central lumen in a similar fashion
to that already described for the former patient. Balloon
of Foley was insuﬄated and left in the uterine cavity.
Endometrium and myometrium were closed, the mold was
ﬁxed to labia majora, and Hyalobarrier gel was applied on
neovaginal walls.
Postoperative followup was similar, and the same proto-
col was used. The patient was discharged from hospital on
15th postoperative day. Her last examination was 16 months
after the surgery when she reported regular and painless
menses and her examination revealed normal vaginal cavity,
cervix, and uterus.
4.Discussion
Vaginal agenesis is an uncommon condition which is
encountered for a few times during the professional career
of a general gynecologist [1, 3]. However, the diagnosis may
considerably unsettle the girl or the young adolescent and
her family. Therefore, attention must be given to the psy-
chosocial issues as well as to the correction of the anatomical
abnormality [7]. Also, counseling about future fertility is of
vital importance. However, normal future fertility may be
expected in patients with isolated vaginal agenesis in whom
normal functioning uterus and intact cervix are present. On
the otherhand, future fertility problemsmay beencountered
due to hematosalpinx, endometriosis, and the surgery itself
which should be emphasized during counseling.
The timing for both nonsurgical and surgical correction
of this anomaly is purely elective [7]. Nevertheless, in
patients with intact uterus experiencing cyclic pelvic pain
due to the obstructed menstrual ﬂuid ﬂow, immediate surgi-
cal correction is mandatory at the time of diagnosis. In the
literature, although more than 10 surgical procedures for
neovaginal reconstruction have been described so far, an
ideal approach has not yet been identiﬁed [8, 9]. Especially
vaginal molds which are used to prevent restenosis of
created neovagina may be associated with most of the
problems. Poor drainage, graft maceration, sloughing, and
graft detachment may be caused by nonideal vaginal molds
and lead to an unsatisfactory reconstruction. Using an
appropriate vaginal mold is one of the keys to achieving4 Case Reports in Medicine
(a) (b)
Figure 6: The Foley catheter passing through the lumen of the mold with its tip located in the uterine cavity ((a) and (b)).
(a) (b)
Figure 7: The mold in neovagina (a) and sutures put in between labia majora and the small holes located at the distal end of the mold (b).
a successful result in McIndoe neovaginal reconstruction
[10, 11]. Since the ﬁrst operation had had the best chance
of success, we were motivated to seek a new vaginal mold
that has advantages for clinical use. For this purpose, we
designed special mold which may speciﬁcally be used for
pubertal girls with complete or partial vaginal agenesis and
a normal uterus where a patent uterocervicovaginal canal
is required to allow normal ﬂow of menstrual and mucosal
ﬂuids. The mold is made up of polymethyl methacrylate
which is commonly used for the production of most denture
base prosthetics. Therefore, it is a relatively simple and a
cheapmoldwhichmaybereadilyproducedindentistrylabo-
ratories in a short period of time. The mold has a length of
9-10cm and a diameter of 2-3cm. It has a central lumen in
which an 8-french pediatric Foley catheter is placed. The tip
of the Foley with the insuﬄated balloon is placed and left in
the uterine cavity to allow the drainage of blood during the
early postoperative period. Also, the Foley allows irrigation
with saline which may be needed to facilitate the drainage of
bloody ﬂuid or to manage postoperative local infection. The
mold we designed has small holes located at both sides of
the distal end which is used to put sutures in between labia
majora and the mold to maintain the mold in position and
to prevent its displacement during the postoperative period.
The surgical technique we described has not only in-
volved the use of a specially designed vaginal mold, but also
Hyalobarrier gel was used which was applied between ne-
ovaginal walls and the mold at the end of the surgery.
Hyalobarrier is an autocrosslinked derivative of hyaluronan
(hyaluronic acid, HA) which is a natural polysaccharide
found in almost all tissuesand body ﬂuids. HAplaysa role in
maintaining the structural integrity of tissues. Hyaluronan
has been recognized in clinical medicine due to its high
degree of biocompatibility, favorable safety proﬁle, tissueCase Reports in Medicine 5
protective properties, and positive biological eﬀects on
healing. The autocrosslinking process increases viscosity and
extends in vivo residence time while preserving the favorable
properties of hyaluronan. Also, the only product of in vivo
degradation is natural HA since no foreign molecules are
usedduringthisprocess[12,13].Duringthehealing process,
prolonged presence of HA in increased amounts was shown
to be associated with lack of ﬁbrosis and scar formation
[14]. Also, exogenous HA was reported to decrease the
synthesis of collagen in human dermal ﬁbroblasts without
eﬀectingendogenousHA synthesis [15]. Actually,deposition
of hyaluronan around surgically treated tissues reduces
postoperative adhesion formation [16]. In this context, use
of Hyalobarrier gel was associated with a reduction in
the incidence and severity of postoperative adhesions after
hysteroscopy, laparoscopy, and laparotomy [17, 18]. Highly
viscous Hyalobarrier gel provides a biodegradable physical
barrier that limits the contact among injured sites for a
protracted period [19]. Hyalobarrier gel use was considered
in this patient due to the assumption that presence of high
amounts of HA on the surgical wound may cause a healing
process without ﬁbrosis and scarring. Given the stenosis of
vagina mostlycaused bythethickscar just at thesurgicalsite,
a second failure might be observed with surgery only. In fact,
successfuluseofHyalobarriergelinsuchaconditionwasﬁrst
reported by our team in the literature previously [20]. As a
result, use of adhesion-preventing agents may be considered
in women who are scheduled for the surgical correction of
vaginal agenesis.
Finally, when a patient is diagnosed to have vaginal
agenesis, she and her family should be counseled in detail
before the surgery. The surgical method with its possible
complications including bladder and rectum injury should
be discussed. Also, they should be informed about relatively
long postoperative care period of almost 6 months which
is critical for the success of the surgery when vaginal mold
is removed and inserted on a daily basis. If postoperative
recommendations are not performed properly, neovaginal
space may be closed, and reobstruction of menstrual ﬂow
may occur which necessitates further surgical interventions.
In conclusion,in femalepatientswith completeorpartial
vaginal agenesis andnormal, functioning uterus,a combined
perineal-abdominal surgical approach may be performed
successfully in association with the use of specially designed
vaginal mold and Hyalobarrier gel. However, further studies
are needed to warrant the use of this surgical technique of
combined perineal-abdominal approach in association with
this type of mold and Hyalobarrier gel or other adhesion-
preventing agents in patients with vaginal agenesis. Also,
abdominal component of the surgery can be completed
laparoscopically in experienced hands which may decrease
the morbidity and provide a faster postoperative recovery
compared to laparotomy.
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